NCT05017454View on ClinicalTrials.gov

Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

April 1, 2023

Conditions
Alopecia Areata
Interventions
DRUG

the optimized sodium valproate-loaded nanospanlastic dispersion

participants will apply the optimized sodium valproate-loaded nanospanlastic dispersion twice daily, on the affected areas of the scalp for 3 months

DRUG

mometasone furoate lotion

participants will apply marketed mometasone furoate lotion twice daily on the affected areas of the scalp for 3 months

Trial Locations (1)

Unknown

Kasralainy Hospital, Dermatology Department, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER